Making Precision Oncology the Standard Worldwide - An Interview with the Precision Cancer Consortium

Gabriele Allegri
Vice President for Global Commercial Precision Medicine
Johnson & Johnson Innovative Medicine

John Longshore
Head of Scientific Affairs for Global Oncology Diagnostics
AstraZeneca
Format: 17 Minute Interview
Register free to attend thought leadership
Do you have a question you’d like Gabriele Allegri, John Longshore to answer during the session?
Register and askRelated posts

Making Precision Oncology the Standard Worldwide - An Interview with the Precision Cancer Consortium

Interview with Viola Heinzelmann Schwarz on the Swiss Tumour Profiler (TuPro) study and OV Precision trial

How Translational Research Can Impact the Development of Precision Medicine
Upcoming events
Harnessing Multi-Omics for Next-Generation Drug Development
Online
Join Tom Lanz, Senior Director of Multi-Omics and Biomarkers, Pfizer to discuss how multi-omics is transforming drug development & the key opportunities and challenges.
Biomarkers & Precision Medicine 2025
In-Person
Europe's flagship event for biomarker innovation returns, advancing drug discovery, development, clinical trials, and precision medicine.
Register for free to view
-
Quickly grasp the key takeaways from cutting-edge biomed research with our bite-sized 5-minute video summaries, before diving into the full presentations from leaders in the industry.
-
From cutting-edge discoveries to real-world applications, see how new research can impact your work, from the lab to commercialisation.
-
Join a community of next-gen scientists, academics and researchers, stay connected, and engage with the latest innovations shaping the future of biomedicine.
Already registered? Sign In.